Short term study on the evidence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
Description
This study will review the potential threat to humans from Middle East Respiratory Syndrome Coronavirus (MERS-CoV). It will review and summarise knowledge about MERS-CoV and its threat to humans in the region and provide recommendations on evidence gaps and on how to address them as a precautionary principle. This review will also look into any on-going research (where identified) to assess the prevalence of Middle East Respiratory Syndrome (MERS) in African camel populations and the epidemiology of the disease in African camels to ascertain how and if the viruses has spread from camels to humans.
Location
The country, countries or regions that benefit from this Programme.
Status Post-completion
The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.
Programme Spend
Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.
Participating Organisation(s)
Help with participating organisations
Accountable:Organisation responsible for oversight of the activity
Extending: Organisation that manages the budget on behalf of the funding organisation.
Funding: Organisation which provides funds.
Implementing: Organisations implementing the activity.
- Accountable
- Funding
- Implementing
Sectors
Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.
Budget
A comparison across financial years of forecast budget and spend to date on the Programme.
Policy Marker(s)
ODA measures in relation to their realisation of OECD development policy objectives
Download IATI Data for GB-1-205090